Elypta

0
11

Elypta is a molecular diagnostic company focused on preventing cancer mortality by developing a liquid biopsy platform for early detection and monitoring of the disease. The approach is based on measurement of 19 biomarkers and use of machine learning algorithms to generate a score against cancer-type specific signatures. Studies have shown exceptional accuracy in renal cell carcinoma. Elypta’s solution is applicable across cancer and will initially serve to improve follow-up of renal cell carcinoma patients.

https://elypta.com/

-- Advertisement --

LEAVE A REPLY

Please enter your comment!
Please enter your name here